Published in J Thromb Haemost on February 01, 2005
Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia. Blood (2011) 2.02
Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm. J Cell Physiol (2011) 1.54
The homocysteine paradox. Arterioscler Thromb Vasc Biol (2008) 1.50
Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol (2008) 1.33
Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood (2006) 1.20
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2008) 1.18
The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer. Antioxid Redox Signal (2014) 1.17
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr (2013) 1.08
Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics (2008) 1.08
Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC). Nephrol Dial Transplant (2011) 1.07
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol (2014) 0.96
Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role? PPAR Res (2010) 0.94
Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94
Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol (2014) 0.93
Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. Springerplus (2013) 0.92
Shear stress inhibits homocysteine-induced stromal cell-derived factor-1 expression in endothelial cells. Circ Res (2009) 0.92
Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res (2009) 0.91
Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age. PLoS One (2011) 0.90
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. Blood (2009) 0.89
Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol (2011) 0.89
The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway. Atherosclerosis (2008) 0.89
High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. World J Gastroenterol (2010) 0.88
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res (2014) 0.87
Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease. World J Gastroenterol (2009) 0.87
Thrombosis and inflammatory bowel disease-the role of genetic risk factors. World J Gastroenterol (2008) 0.86
Treatment of risk factors to prevent stroke. Neurotherapeutics (2011) 0.86
Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study. Hum Genet (2007) 0.84
Pulmonary thromboembolism due to severe hyperhomocysteinemia associated with a methyltetrahydrofolate reductase mutation. Korean J Intern Med (2012) 0.84
The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism. Thromb Res (2013) 0.83
Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells. Amino Acids (2015) 0.81
The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults. J Clin Endocrinol Metab (2013) 0.81
Hepatitis C Virus Infection Associated With an Increased Risk of Deep Vein Thrombosis: A Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.80
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy. J Exp Clin Assist Reprod (2008) 0.79
Methylenetetrahydrofolate reductase C677T mutation and risk of retinal vein thrombosis. J Res Med Sci (2013) 0.78
Medical management of venous thromboembolism: what the interventional radiologist needs to know. Semin Intervent Radiol (2012) 0.78
Homocysteine and its relationship to deep venous thrombosis in patients undergoing total knee or hip arthroplasty. Hippokratia (2010) 0.78
Priming effect of homocysteine on inducible vascular cell adhesion molecule-1 expression in endothelial cells. Biomed Pharmacother (2008) 0.77
The 844ins68 cystathionine beta-synthase and C677T MTHFR gene polymorphism and the vaso-occlusive event risk in sickle cell disease. Arch Med Sci (2011) 0.77
Improved real-time multiplex polymerase chain reaction detection of methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C polymorphisms using nearest neighbor model-based probe design. J Mol Diagn (2007) 0.77
Genetic epidemiology in aging research. J Gerontol A Biol Sci Med Sci (2009) 0.77
Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores). Thromb J (2009) 0.76
Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience. J Med Life (2015) 0.75
Laboratory informatics based evaluation of methylene tetrahydrofolate reductase C677T genetic test overutilization. J Pathol Inform (2013) 0.75
Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trial. J Pharmacol Pharmacother (2014) 0.75
The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity. Medicine (Baltimore) (2016) 0.75
Vascular Genetic Variants and Ischemic Stroke Susceptibility in Albanians from the Republic of Macedonia. Open Access Maced J Med Sci (2016) 0.75
Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects. Biomed Res Int (2015) 0.75
Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina. Balkan J Med Genet (2016) 0.75
The TT genotype of methylenetetrahydrofolate reductase 677C>T polymorphism increases the susceptibility to pediatric ischemic stroke: meta-analysis of the 822 cases and 1,552 controls. Mol Biol Rep (2012) 0.75
The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan Med J (2013) 0.75
Opportunism: a panacea for implementation of whole-genome sequencing studies in nutrigenomics research? Genes Nutr (2014) 0.75
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol (1999) 6.42
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol (1992) 3.15
Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J (2002) 3.09
Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst (1997) 2.88
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70
Cerebral hemispheric asymmetry in humans. Cortical speech zones in 100 adults and 100 infant brains. Arch Neurol (1975) 2.21
Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr (2009) 2.07
Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol (1991) 1.88
Structural basis for the conducting interface between LaAlO3 and SrTiO3. Phys Rev Lett (2007) 1.76
MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. Cancer Res (1997) 1.74
Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy. J Natl Cancer Inst (1996) 1.60
A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci U S A (1997) 1.60
C-terminal deletion mutants of the FokI restriction endonuclease. Gene (1993) 1.58
Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease. J Intern Med (2014) 1.48
Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. J Intern Med (2010) 1.47
Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk (1998) 1.43
Coherent control of pulsed X-ray beams. Nature (2001) 1.41
Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age. Eur Heart J (2002) 1.41
Homocysteine and brain atrophy on MRI of non-demented elderly. Brain (2003) 1.40
Holistic vets must prove their treatments. Aust Vet J (2001) 1.40
The importance of cholesterol, blood pressure and smoking for coronary heart disease. Eur Heart J (2003) 1.38
On the constancy of the number of villi in the duodenum of the post-embryonic domestic fowl. J Embryol Exp Morphol (1967) 1.37
Vestibular control of sympathetic activity. An otolith-sympathetic reflex in humans. Exp Brain Res (2002) 1.36
ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer (2003) 1.32
Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res (1993) 1.32
MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res (1993) 1.32
Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family. Genomics (2000) 1.30
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer (1999) 1.30
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J (2004) 1.24
Free healthy breakfasts in primary schools: a cluster randomised controlled trial of a policy intervention in Wales, UK. Public Health Nutr (2010) 1.24
Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology (2002) 1.24
Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep (1999) 1.19
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk (2001) 1.17
From collaboration to commissioning: developing relationships between primary health and social services. BMJ (1998) 1.17
Approaches to working in high-dimensional data spaces: gene expression microarrays. Br J Cancer (2008) 1.17
Rapid oxidation in vitro of endogenous and exogenous glutathione in bile of rats. J Biol Chem (1981) 1.16
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer (1996) 1.16
Asking pregnant women about HIV risk. N Z Med J (1998) 1.14
Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-1993. Int J Tuberc Lung Dis (1997) 1.13
Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks. Virology (1988) 1.06
North of England and Scotland Study of Tonsillectomy and Adeno-tonsillectomy in Children(NESSTAC): a pragmatic randomised controlled trial with a parallel non-randomised preference study. Health Technol Assess (2010) 1.06
Mental health consultation improves care of the aged in community facilities. Hosp Community Psychiatry (1974) 1.04
Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies. Cancer Res (1994) 1.03
Naturally occurring extracellular matrix as a scaffold for musculoskeletal repair. Clin Orthop Relat Res (1999) 1.01
The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity. Cancer Res (1991) 1.01
The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis (1993) 0.99
Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet (2000) 0.99
Probing impulsive strain propagation with X-ray pulses. Phys Rev Lett (2001) 0.99
Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int J Cancer (1992) 0.98
Use of hierarchical models for meta-analysis: experience in the metabolic ward studies of diet and blood cholesterol. Stat Med (1999) 0.98
Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen. Br J Cancer (1987) 0.98
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer (1997) 0.97
Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta. J Natl Cancer Inst (1999) 0.95
Interleukin-1 levels in the supernatant of conditioned media of embryos grown in autologous endometrial coculture: correlation with outcome after in vitro fertilization. Am J Reprod Immunol (2000) 0.95
Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat (1994) 0.95
Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin Cancer Res (2000) 0.95
Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol (1998) 0.95
Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res (1994) 0.95
Chronic cadmium poisoning. Med J Aust (1976) 0.94
Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol Rep (1998) 0.94
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93
Concentration of antibiotics in normal bone after intravenous injection. J Bone Joint Surg Am (1978) 0.93
Nutritional rehabilitation increases resting energy expenditure without affecting protein turnover in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (1991) 0.93
Postmortem cerebrospinal fluid pleocytosis. Am J Forensic Med Pathol (1989) 0.92
Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Int J Cancer (1994) 0.91
Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J Steroid Biochem Mol Biol (2000) 0.91
Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer (1999) 0.91
Effect of gamma-irradiation on beef myoglobin. J Agric Food Chem (1971) 0.90
Aspergillar osteomyelitis of the acetabulum. A case report and review of the literature. Orthop Rev (1990) 0.90
Regulation of human breast cancer by secreted growth factors. Acta Oncol (1989) 0.89
Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes. Breast Cancer Res Treat (1996) 0.89
A comparative analysis of methods of estimating the size of cell populations from microtome sections. J R Microsc Soc (1968) 0.89
The influence of maternal diet on breast cancer risk among female offspring. Nutrition (1999) 0.89
Injury surveillance in Trinidad: an accident and emergency based injury surveillance system at the San Fernando General Hospital. West Indian Med J (2009) 0.89
Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors. Cancer Cells (1989) 0.88
The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer. Int J Breast Cancer (2011) 0.88
Identifying early events of gene expression in breast cancer with systems biology phylogenetics. Cytogenet Genome Res (2013) 0.88
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs. Acta Oncol (1992) 0.87
Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 0.87
Effect of massage of the hamstring muscles on selected electromyographic characteristics of biceps femoris during sub-maximal isometric contraction. Int J Sports Med (2007) 0.87
Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17 beta-oestradiol in a human breast carcinoma cell line, MDA-MB-436. Eur J Cancer Clin Oncol (1983) 0.87
Effect of massage of the hamstring muscle group on performance of the sit and reach test. Br J Sports Med (2004) 0.86
Effect of refeeding on the energy metabolism of adolescent girls who have anorexia nervosa. Eur J Clin Nutr (1991) 0.86
Transient strain driven by a dense electron-hole plasma. Phys Rev Lett (2003) 0.86
Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH. Breast Cancer Res Treat (1992) 0.86
Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol. Br J Cancer (1985) 0.86
Variation in European antibiotic use. Lancet (2001) 0.85
Risk factors for smoking among school adolescents in Greece. Child Care Health Dev (2008) 0.85
Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis. Clin Chem Lab Med (2007) 0.85
Localized fibrous tumors of the pleura: correlation of histopathological, immunohistochemical and ultrastructural features. Pathol Res Pract (1990) 0.85
Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase. Mol Pharmacol (2001) 0.85